Cecilian Partners Ranks No. 1,033 on the 2024 Inc. 5000
Exceptional three-year growth landed Cecilian among the top 20% of America's fastest-growing private companies
"Being part of the Inc. 5000 has long been a goal of mine. One of my favorite business leaders,
He continued, "It's wonderful to have a national publication that goes beyond the 'pay to play' mentality to recognize the immense efforts of companies and entrepreneurs. To qualify for this recognition, you have to pull back the curtain on your leadership and your finances—you're either for real, or you're not."
The Inc. 5000 class of 2024 represents companies that drove rapid revenue growth while navigating inflationary pressures, rising costs of capital, and ongoing hiring challenges. In all, this year's Inc. 5000 companies added 874,458 jobs to the economy over the past three years.
Cecilian Partners secured its ranking with revenue growth of more than 350%. Since its founding in 2019, Cecilian's cofounders have focused on residential real estate, primarily new home construction. The company's Residential Operating System™ digitizes the entire development process, from land to lots to homes to engaging residents in master planned communities.
Headquartered in southeastern
"To see all of the intriguing and surprising ways that companies are transforming sectors, from health care and AI to apparel and pet food, is fascinating for me as a journalist and storyteller," says
Complete results of the Inc. 5000 can be found at www.inc.com/inc5000.
About Cecilian Partners
Cecilian Partners collaborates with developers and homebuilders across the
View original content to download multimedia:https://www.prnewswire.com/news-releases/cecilian-partners-ranks-no-1-033-on-the-2024-inc-5000--302221236.html
SOURCE Cecilian Partners
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cuvo Health Publishes 2026 State-by-State Virtual Clinic Compliance Report: 33 of 51 Jurisdictions Restrict the Corporate Practice of Medicine
- Global Validation of EOP Sound and #1 Chart Success of "Music in My Mind"
- Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share